Protective potential of piroxicam on human peripheral blood mononuclear cells against the suppressive capacity of glioblastoma cell lines
Abstract Dexamethasone, a common medication used in the treatment regimen of glioblastoma, has broad inhibitory effects on the immune responses. Here, in an in vitro study, we examined the effects of piroxicam, a potent substitute for dexamethasone, on peripheral blood mononuclear cells (PBMCs) co-c...
Main Authors: | Jahangir Abdesheikhi, Farnaz Sedghy, Alireza Farsinejad, Merat Mahmoudi, Mahdi ranjkesh, Meysam Ahmadi-Zeidabadi |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-11-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-24392-2 |
Similar Items
-
Silibinin improved the function of T cells in peripheral blood mononuclear cells (PBMCs) co-cultured with U-87 MG cell line
by: Banafshe Abadi, et al.
Published: (2024-03-01) -
Enhancement the antioxidative and immunomodulatory functions of mesenchymal stem cells by tetrandrine
by: Shohreh Fadaghi, et al.
Published: (2024-08-01) -
Suppression of Gelatinase Activity in Human Peripheral Blood Mononuclear Cells by Verapamil
by: Fatemeh Hajighasemi, et al.
Published: (2014-03-01) -
Exosome-loaded Paclitaxel: Preparation and toxicity evaluation on two glioblastoma cell lines
by: Soodeh Salarpour, et al.
Published: (2019-12-01) -
Cytotoxic Effect of Recombinant Fragaceatoxin C on Peripheral Blood Mononuclear Cells
by: Leyla Darbarfard, et al.
Published: (2020-08-01)